1-4 of 4
Thomas G. Bumm
Close
Sort by
Journal Articles

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Shigeo Fuji, Julia Fischer, Markus Kapp, Thomas G Bumm, MD, Hermann Einsele, Stefan Stevanovic, PhD, Hans-Georg Rammensee, Prof., Thomas Hunig, Götz Ulrich Grigoleit, MD
Journal: Blood
Blood (2012) 120 (21): 4351.
https://doi.org/10.1182/blood.V120.21.4351.4351
Published: 2012
Journal Articles

TNFα facilitates clonal expansion of JAK2 V617F positive cells in myeloproliferative neoplasms

Angela G. Fleischman, Karl J. Aichberger, Samuel B. Luty, Thomas G. Bumm, Curtis L. Petersen, Shirin Doratotaj, Kavin B. Vasudevan, Dorian H. LaTocha, Fei Yang, Richard D. Press, Marc M. Loriaux, Heike L. Pahl, Richard T. Silver, Anupriya Agarwal, Thomas O'Hare, Brian J. Druker, Grover C. Bagby, Michael W. Deininger
Journal: Blood
Blood (2011) 118 (24): 6392–6398.
https://doi.org/10.1182/blood-2011-04-348144
Published: 2011
Includes: Supplemental data
Journal Articles

Jak2 V617F Induced TNF Resistance as a Mechanism of Clonal Expansion In Myeloproliferative Neoplasm

Angela G. Fleischman, MD, PhD, Karl J. Aichberger, MD, PhD, Curtis L Petersen, Shirin Doratotaj, MD, Thomas G Bumm, MD, Heike L. Pahl, PhD, Brian J Druker, MD, Michael W Deininger, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 795.
https://doi.org/10.1182/blood.V116.21.795.795
Published: 2010
Journal Articles

CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms

Jeffrey W. Tyner, Thomas G. Bumm, Jutta Deininger, Lisa Wood, Karl J. Aichberger, Marc M. Loriaux, Brian J. Druker, Christopher J. Burns, Emmanuelle Fantino, Michael W. Deininger
Journal: Blood
Blood (2010) 115 (25): 5232–5240.
https://doi.org/10.1182/blood-2009-05-223727
Published: 2010
Includes: Supplemental data